Clinical Trials Directory

Trials / Completed

CompletedNCT02353234

Bioavailability of Phenolic Compounds in Bread

Bioavailability of Phenolic Compounds in Wholegrain Bread Compared With White Bread Enriched With Aleurone Fraction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University of Parma · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The consumption of wholemeal cereals has been associated with the reduction of several chronic diseases. The mechanisms behind these protective effects may be linked, besides dietary fiber and micronutrients, to an increased intake of phenolic compounds, mainly, hydroxycinnamates contained in the bran. Among bran fractions, aleurone usually contains the highest concentration of ferulic acid, principally contained as monomeric form and diferulic acid esters linked to arabinoxylans, representing the most relevant subclasses. The aim of the study was to evaluate the absorption of hydroxycinnamates by measuring the urinary excretion of phenolic metabolites in humans fed with two different kind of a commercial bread, as wholegrain bread and a white bread enriched with aleurone fraction. Moreover, the pharmacokinetics of the main phenolic compounds was also evaluated by measuring the circulating metabolites in plasma samples.

Conditions

Interventions

TypeNameDescription
OTHERBreadIn each arm subjects consume bread

Timeline

Start date
2014-12-01
Primary completion
2015-06-01
Completion
2015-07-01
First posted
2015-02-02
Last updated
2015-12-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02353234. Inclusion in this directory is not an endorsement.

Bioavailability of Phenolic Compounds in Bread (NCT02353234) · Clinical Trials Directory